Cargando…
Cardiac Alterations in Human African Trypanosomiasis (T.b. gambiense) with Respect to the Disease Stage and Antiparasitic Treatment
BACKGROUND: In Human African Trypanosomiasis, neurological symptoms dominate and cardiac involvement has been suggested. Because of increasing resistance to the available drugs for HAT, new compounds are desperately needed. Evaluation of cardiotoxicity is one parameter of drug safety, but without kn...
Autores principales: | Blum, Johannes A., Schmid, Caecilia, Burri, Christian, Hatz, Christoph, Olson, Carol, Fungula, Blaise, Kazumba, Leon, Mangoni, Patrick, Mbo, Florent, Deo, Kambau, Mpanya, Alain, Dala, Amadeo, Franco, Jose R., Pohlig, Gabriele, Zellweger, Michael J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640099/ https://www.ncbi.nlm.nih.gov/pubmed/19221604 http://dx.doi.org/10.1371/journal.pntd.0000383 |
Ejemplares similares
-
African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005) -
Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial
por: Pohlig, Gabriele, et al.
Publicado: (2016) -
Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022) -
Accuracy of Five Algorithms to Diagnose Gambiense Human African Trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2011) -
Is vector control needed to eliminate gambiense human African trypanosomiasis?
por: Solano, Philippe, et al.
Publicado: (2013)